D
Relmada Therapeutics, Inc. RLMD
$0.627 $0.0172.79% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -9.87M -17.56M -18.66M -21.73M -17.77M
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 3.44M 4.26M 6.97M 7.52M 7.13M
Change in Net Operating Assets 24.90K -4.77M 2.89M -2.45M -2.62M
Cash from Operations -6.40M -18.07M -8.80M -16.66M -13.26M
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 6.68M 15.36M 11.35M 16.14M 14.01M
Cash from Investing 6.68M 15.36M 11.35M 16.14M 14.01M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- 0.00 0.00 0.00
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -73.00K -- -172.50K -89.60K 0.00
Cash from Financing -73.00K -- -172.50K -89.60K 0.00
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 203.60K -2.71M 2.37M -602.50K 751.20K